Literature DB >> 25750075

Kidney transplantation in children with decreased left ventricular systolic function: a Midwest Pediatric Nephrology Consortium study.

Sandeep K Riar1, Mark M Mitsnefes, Edward J Nehus, Hiren P Patel, Julia M Steinke, Teri Crumb, Elizabeth C Abraham, Margret W Kamel, Larry A Greenbaum.   

Abstract

BACKGROUND: Left ventricular (LV) systolic dysfunction is a relatively uncommon but serious complication of pediatric chronic kidney disease, and may be related to uremia and uncontrolled hypertension. There is limited information on the strategy for managing these children. In some cases, combined heart-kidney transplant may be considered or kidney transplant delayed until cardiac function improves. It is unknown whether these patients are at increased risk for poor outcomes after kidney transplantation.
METHODS: We conducted a retrospective, multicenter study on the outcomes of children with severe and symptomatic cardiomyopathy who underwent kidney transplantation.
RESULTS: Eleven patients receiving maintenance dialysis with systolic dysfunction underwent kidney transplantation without simultaneous heart transplant. Nine patients had congestive heart failure in the pre-transplant period. There were no identified complications post-transplant related to the underlying cardiac dysfunction. LV systolic function normalized in all patients and the mean shortening fraction increased from 19.0 ± 4.6 % to 32.0 ± 4.4 % (p < 0.0001).
CONCLUSIONS: Kidney transplantation should be considered for children receiving maintenance dialysis with severe LV dysfunction.

Entities:  

Mesh:

Year:  2015        PMID: 25750075     DOI: 10.1007/s00467-015-3066-x

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  30 in total

1.  Kidney transplantation in patients with ventricular ejection fraction less than 50 percent: features and posttransplant outcome.

Authors:  J L Melchor; R Espinoza; C Gracida
Journal:  Transplant Proc       Date:  2002-11       Impact factor: 1.066

2.  End-stage renal disease and cardiomyopathy in children: cardiac effects of renal transplantation.

Authors:  Ashwin K Lal; Andreas R de Biasi; Steve Alexander; David N Rosenthal; Scott M Sutherland
Journal:  Transplantation       Date:  2012-01-27       Impact factor: 4.939

3.  Diffuse intermyocardiocytic fibrosis in uraemic patients.

Authors:  G Mall; W Huther; J Schneider; P Lundin; E Ritz
Journal:  Nephrol Dial Transplant       Date:  1990       Impact factor: 5.992

4.  Plasma noradrenaline levels in regular haemodialysis patients.

Authors:  H M Brecht; W Ernst; K M Koch
Journal:  Proc Eur Dial Transplant Assoc       Date:  1976

5.  Characteristics of a subset of patients with reversible systolic dysfunction in chronic kidney disease.

Authors:  Srilakshmi M Adhyapak; Shamanna S Iyengar
Journal:  Congest Heart Fail       Date:  2011-04-18

6.  Reduction of left ventricular hypertrophy in children undergoing hemodialysis.

Authors:  Tim Ulinski; Julie Genty; Christine Viau; Isabelle Tillous-Borde; Georges Deschênes
Journal:  Pediatr Nephrol       Date:  2006-06-01       Impact factor: 3.714

7.  Reduced chronotropic responsiveness of the heart in experimental uremia.

Authors:  J F Mann; K H Jakobs; J Riedel; E Ritz
Journal:  Am J Physiol       Date:  1986-05

8.  Norepinephrine-induced left ventricular dysfunction in anesthetized and conscious, sedated dogs.

Authors:  A Movahed; W C Reeves; P M Mehta; M G Gilliland; S L Mozingo; S R Jolly
Journal:  Int J Cardiol       Date:  1994-06-01       Impact factor: 4.164

9.  Improved left ventricular mass index in children after renal transplantation.

Authors:  Rachel Becker-Cohen; Amiram Nir; Efrat Ben-Shalom; Choni Rinat; Sofia Feinstein; Benjamin Farber; Yaacov Frishberg
Journal:  Pediatr Nephrol       Date:  2008-06-12       Impact factor: 3.714

10.  Impact of renal transplantation on uremic cardiomyopathy.

Authors:  P S Parfrey; J D Harnett; R N Foley; G M Kent; D C Murray; P E Barre; R D Guttmann
Journal:  Transplantation       Date:  1995-11-15       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.